Clinical Trial Update: A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BL-B01D1 in combination with an anti-PD-1 monoclonal antibody for extensive-stage small cell lung cancer; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• BL-B01D1
• PD-1 monoclonal antibody

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Extensive-stage Small-cell Lung Cancer | Phase 2 | Status: RECRUITING